EUVIMEDEUVIMED entdecken
Crossref

SRS388 - Pancreatic resectability evaluation through deep imaging with computed tomography in pancreatic cancer

Vincent Ochs, Christoph Kümmerli, Julia Wolleb, Joël Lavanchy, Julia Ruppel, Jan Liechti, Stephanie Taha-Mehlitz, Christian Andreas Nebiker, Beat Müller, Giuseppe Kito Fusai, Philippe Cattin, Sebastian Staubli

British Journal of Surgery · 27.03.2026 · 113 (Supplement_2)

DOI: 10.1093/bjs/znag018.344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 27.03.2026. Verfasst von Vincent Ochs und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pancreatic ductal adenocarcinoma (PDAC) has the highest mortality of solid malignancies (Sung H, CA Cancer J Clin). Surgical resection is the only curative option (NCCN Guidelines, 2019), yet accurate determination of resectability is difficult. Defined by vascular involvement, assessment suffers from low inter-observer agreement. Automated deep learning may provide standardized, reproducible support for operability assessment.

Methods

We developed an end-to-end multimodal pipeline to predict PDAC operability (resectable, borderline, irresectable) by integrating contrast-enhanced CT and clinical data. CT scans were processed using a SwinUNETR backbone. The encoder produced imaging features, while the decoder generated 16-class segmentations of pancreas, tumor, and vessels. Seventeen clinical variables underwent projection into an embedding. Imaging and tabular embeddings were concatenated and classified via a multilayer perceptron. Training used a multi-task loss combining segmentation (Dice, weighted cross-entropy, focal) and classification (weighted cross-entropy) with adaptive weighting. Evaluation used stratified 5-fold cross-validation and grid search optimization.

Results

Among 159 patients, 85 (53.5%) were resectable, 47 (29.5%) borderline, and 27 (17%) irresectable. Cross-validation yielded a mean Dice of 75.2% across 16 classes, including 70.4% for tumor, 69.7% for the superior mesenteric artery, and 65.1% for the vein. Operability prediction reached 85.1% accuracy, exceeding prior methods (70–88%) on smaller datasets.

Conclusions

Our model shows feasibility for automated PDAC operability prediction. By leveraging segmentation as an auxiliary task, it learns anatomically relevant features enhancing classification. Unlike segmentation-only approaches (Viviers, Bereska), our pipeline fuses imaging and clinical data. Future work includes multi-institutional validation and a prospective clinical trial via Pancreasgroup.org.

Zitieren

APA

Ochs, V., Kümmerli, C., Wolleb, J., Lavanchy, J., Ruppel, J., Liechti, J., Taha-Mehlitz, S., Nebiker, C. A., Müller, B., Fusai, G. K., Cattin, P., & Staubli, S. (2026). SRS388 - Pancreatic resectability evaluation through deep imaging with computed tomography in pancreatic cancer. British Journal of Surgery, 113(Supplement_2). https://doi.org/10.1093/bjs/znag018.344

Vancouver

Ochs V, Kümmerli C, Wolleb J, Lavanchy J, Ruppel J, Liechti J, et al. SRS388 - Pancreatic resectability evaluation through deep imaging with computed tomography in pancreatic cancer. British Journal of Surgery. 2026;113(Supplement_2). doi:10.1093/bjs/znag018.344

BibTeX
@article{Ochs2026,
  author = {Ochs, Vincent and Kümmerli, Christoph and Wolleb, Julia and Lavanchy, Joël and Ruppel, Julia and Liechti, Jan and Taha-Mehlitz, Stephanie and Nebiker, Christian Andreas and Müller, Beat and Fusai, Giuseppe Kito and Cattin, Philippe and Staubli, Sebastian},
  title = {SRS388 - Pancreatic resectability evaluation through deep imaging with computed tomography in pancreatic cancer},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_2},
  doi = {10.1093/bjs/znag018.344}
}
Kostenlos starten →